Market closed

Arcellx/$ACLX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Arcellx

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Ticker

$ACLX
Trading on

Industry

Biotechnology

Employees

130

Arcellx Metrics

BasicAdvanced
$4.7B
Market cap
-
P/E ratio
-$0.77
EPS
0.27
Beta
-
Dividend rate
$4.7B
0.27
$107.37
$46.42
599K
4.286
4.216
9.775
13.526
-34.71%
-6.29%
-10.79%
29.169
9.72
9.72
1,268.503
230.33%
-72.03%
-82.07%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ACLX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Arcellx stock?

Arcellx (ACLX) has a market cap of $4.7B as of December 13, 2024.

What is the P/E ratio for Arcellx stock?

The price to earnings (P/E) ratio for Arcellx (ACLX) stock is 0 as of December 13, 2024.

Does Arcellx stock pay dividends?

No, Arcellx (ACLX) stock does not pay dividends to its shareholders as of December 13, 2024.

When is the next Arcellx dividend payment date?

Arcellx (ACLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Arcellx?

Arcellx (ACLX) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.